Law Office of Brodsky & Smith, LLC Announces Investigation of ZOLL Medical Corporation
20 Março 2012 - 1:50PM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
ZOLL Medical Corporation (“ZOLL” or the “Company”) (Nasdaq: ZOLL)
relating to the proposed acquisition by Asahi Kasei Corporation
(“Asahi”).
Under the terms of the transaction, ZOLL shareholders would
receive $93.00 in cash for each share of ZOLL stock they own. The
investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of ZOLL for
not acting in the Company’s shareholders' best interests in
connection with the sale process to Asahi. The transaction may
undervalue ZOLL as a result of failing to adequately shop the
Company. The price being paid by Asahi is both below the premium
paid in comparable transactions and below an analyst $100.00 per
share price target.
If you own shares of ZOLL stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L. Brodsky, Esquire or Evan J.
Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, visiting
http://brodsky-smith.com/395-zoll-zoll-medical-corporation.html, or
by calling toll free 877-LEGAL-90.
Zoll (NASDAQ:ZOLL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Zoll (NASDAQ:ZOLL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Zoll Medical Corp. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Brodsky & Smith, LLC